Internal Medicine · Commack, NY
NPI
1265538458
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2171 Jericho Tpke, Suite 100
Commack, NY, 11725
Phone (631) 343-7242
Groups this clinician bills Medicare through
Medicare paid, 2024
$393K
15,657 services
Medicare patients, 2024
477
Average age 75
Drug cost, 2024
$3.1M
9,448 prescriptions
Company payments, 2025
$36K
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan S Lown was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,466 times for 39 patients. In total Jonathan S Lown billed 15,657 services in 109 codes, and Medicare paid $393K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,466 | 39 | $0.10 | $543 |
| 99214 Office E&M - Established | Office | 830 | 340 | $99.62 | $83K |
| 99215 Office E&M - Established | Office | 728 | 221 | $148.12 | $108K |
| 36415 Venipuncture Blood Collection | Office | 710 | 212 | $8.65 | $6,142 |
| J0897 Injection, denosumab, 1 mg | Office | 660 | 11 | $19.72 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 537 | 278 | $13.55 | $7,276 |
| 96372 Injection Administration | Office | 280 | 108 | $11.76 | $3,294 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 277 | 53 | $0.34 | $95.32 |
| 81002 Clinical Chemistry | Office | 209 | 108 | $3.41 | $713 |
| 99213 Office E&M - Established | Office | 197 | 138 | $70.35 | $14K |
| 95800 Sleep Study | Office | 187 | 153 | $111.86 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 187 | 29 | $0.69 | $129 |
| 93000 Electrocardiogram | Office | 130 | 97 | $11.76 | $1,529 |
| G0008 Administration of influenza virus vaccine | Office | 89 | 89 | $37.09 | $3,301 |
| 90653 Vaccine Product | Office | 86 | 86 | $81.82 | $7,037 |
By year: 2022 $490K for 18,778 services; 2023 $404K for 12,358 services; 2024 $393K for 15,657 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 710 | 212 | $8.65 | $6,142 |
| 81002 Clinical Chemistry | 209 | 108 | $3.41 | $713 |
| 87428 Infectious Agent Detection by DNA/RNA | 69 | 54 | $66.85 | $4,613 |
| 82270 Immunoassay | 38 | 38 | $4.29 | $163 |
| 82272 Immunoassay | 16 | 15 | $4.15 | $66.4 |
| 82044 Clinical Chemistry | 12 | 11 | $6.11 | $73.32 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan S Lown prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 516 prescriptions and refills. In total Jonathan S Lown wrote 9,448 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 516 | 556 | 82 | $566K |
| Ezetimibe Generic | 443 | 1,133 | 124 | $12K |
| Rosuvastatin Calcium Generic | 431 | 1,072 | 115 | $5,321 |
| Repatha Sureclick Evolocumab | 278 | 457 | 60 | $249K |
| Atorvastatin Calcium Generic | 240 | 683 | 70 | $2,302 |
| Levothyroxine Sodium Generic | 188 | 472 | 48 | $3,224 |
| Metoprolol Succinate Generic | 182 | 429 | 46 | $2,357 |
| Montelukast Sodium Generic | 182 | 384 | 54 | $1,745 |
| Nexlizet Bempedoic Acid/Ezetimibe | 174 | 419 | 47 | $161K |
| Duloxetine Hcl Generic | 157 | 302 | 48 | $4,852 |
| Pregabalin Generic | 151 | 191 | 42 | $6,878 |
| Farxiga Dapagliflozin Propanediol | 148 | 240 | 31 | $133K |
| Tamsulosin Hcl Generic | 143 | 361 | 43 | $2,766 |
| Amlodipine Besylate Generic | 133 | 345 | 40 | $861 |
| Ozempic Semaglutide | 133 | 163 | 26 | $143K |
Brand drugs: 2,869 claims; generic drugs: 6,530 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan S Lown $36K ($36K in general payments such as food, travel and fees) from 43 companies. The largest payer was Jazz Pharmaceuticals Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 34 | $20K |
| Harmony Biosciences LLC HRMY | 45 | $11K |
| Amgen Inc. AMGN | 41 | $953 |
| Sumitomo Pharma America, Inc. 4506.T | 23 | $441 |
| Axsome Therapeutics, Inc. AXSM | 19 | $375 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $254 |
| Astellas Pharma US Inc 4503.T | 6 | $210 |
| Esperion Therapeutics, Inc. ESPR | 16 | $208 |
| Azurity Pharmaceuticals, Inc. | 20 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $196 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.